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background:  There are few data in the literature analyzing the very old population, especially in comparison with middle age/young population, 
main objective of the present study.
methods: From 4889 patients with acute coronary syndromes (ACS) included prospectively and consecutively in a dedicated databank between 
01/2008 and 01/2013, we selected 552 with age >80 years, and 768 with <50 years. Both groups were analyzed taking into account the first 
(N=578) and second half (Group II, N=742) of the follow-up. The percentage of prescription of the following therapies at hospital discharge was 
analyzed: aspirin, statin, betablocker, clopidogrel, ACE inhibitor/ARB; during hospitalization, primary angioplasty, non-primary angioplasty and 
surgical revascularization were analyzed.
results: in the elderly population the utilization of statin (53.2% to 92%, P<0.001), clopidogrel (49.3% to 67.2%, P=0.005) and non-primary 
angioplasty (26.2 to 35.8, P=0.018) increased significantly in the two analyzed periods; for the younger population, the use of aspirin decreased 
significantly (96.2% to 92.1%, P=0.039), whereas statin (48.9% to 91.9%, P<0.001), clopidogrel (61.5% to 76.7%, P=0.004), ACE inhibitor/ARB 
(61.2% to 79.7%, P<0.001), betablocker (72.2% to 88.1%, P<0.001) and primary angioplasty (19.8% to 26%, P=0.041) increased significantly. 
During the analyzed periods, the 14-day mortality decreased from 17.8% to 7.7% (P<0.001) in the elderly group, and from 2.7% to 0.5% in the 
younger group (P=0.012). Finally, the 1-year survival increased from 58.2% ± 0.037 to 79.7% ± 0.030 in the elderly group (P<0.001), and from 
90.7% ± 0.018 to 96.5% ± 0.013 in the younger group (P=0.001, P<0.001 for the comparison between elderly and younger groups).
Conclusion: The treatment of ACS is improving in both the very old and younger populations, but the impact of this improvement in terms of 
mortality is higher for the elderly.
